<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>4</Volume>
				<Issue>9</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Methadone Maintenance Treatment Program in Prisons from the Perspective of Medical and non-Medical Prison Staff: A Qualitative Study in Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>583</FirstPage>
			<LastPage>589</LastPage>
			<ELocationID EIdType="pii">2988</ELocationID>
			
<ELocationID EIdType="doi">10.15171/ijhpm.2015.60</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ghobad</FirstName>
					<LastName>Moradi</LastName>
<Affiliation>Kurdistan  Research  Center  for  Social  Determinants  of  Health  (KRCSDH), 
Kurdistan  University  of  Medical  Sciences,  Sanandaj,  Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2612-6528</Identifier>

</Author>
<Author>
					<FirstName>Marzieh</FirstName>
					<LastName>Farnia</LastName>
<Affiliation>Iran  Prisons 
Organization,  Health  and  Treatment  Department,  Tehran,  Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Shokoohi</LastName>
<Affiliation>Regional 
Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute 
for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 
Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-3810-752X</Identifier>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Shahbazi</LastName>
<Affiliation>GFATM  Projects  in  Prisons,  United  Nations  Development  Program, 
Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Moazen</LastName>

						<AffiliationInfo>
						<Affiliation>Non-Communicable Diseases Research Center, Endocrinology 
and  Metabolism  Population  Sciences  Institute,  Tehran  University  of  Medical 
Sciences,  Tehran,  Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Endocrinology  and  Metabolism  Research  Center, 
Endocrinology  and  Metabolism  Clinical  Sciences  Institute,  Tehran  University 
of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Khaled</FirstName>
					<LastName>Rahmani</LastName>
<Affiliation>School of Public Health, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2014</Year>
					<Month>11</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>Background &lt;br /&gt;As one of the most important components of harm reduction strategy for high-risk groups, following the HIV epidemics, Methadone Maintenance Treatment (MMT) has been initiated in prisoners since 2003. In this paper, we aimed to assess the advantages and shortcomings of the MMT program from the perspective of people who were involved with the delivery of prison healthcare in Iran. &lt;br /&gt;  &lt;br /&gt;Methods &lt;br /&gt;On the basis of grounded theory and through conducting 14 Focus Group Discussions (FGDs), 7 FGDs among physicians, consultants, experts, and 7 FGDs among directors and managers of prisons (n= 140) have been performed. The respondents were asked about positive and negative elements of the MMT program in Iranian prisons. &lt;br /&gt;  &lt;br /&gt;Results &lt;br /&gt;This study included a total of 48 themes, of which 22 themes were related to advantages and the other 26 were about shortcomings of MMT programs in the prisons. According to participants’ views “reduction of illegal drug use and high-risk injection”, “reduction of potentially high-risk behaviors” and “making positive attitudes” were the main advantages of MMT in prisons, while issues such as “inaccurate implementation”, “lack of skilled manpower” and “poor care after release from prison” were among the main shortcomings of MMT program. &lt;br /&gt;  &lt;br /&gt;Conclusions &lt;br /&gt;MMT program in Iran’s prisons has achieved remarkable success in the field of harm reduction, but to obtain much more significant results, its shortcomings and weaknesses must be also taken into account by policy-makers.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Methadone Maintenance Treatment (MMT)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Harm Reduction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prisoners</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Substance Use</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">High-Risk</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Behaviors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">HIV</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_2988_faa453efde4ac6a36849ba381feb9e87.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
